National Medication Management Initiative Experiencing Tremendous Industry Acceptance

Averlent Corporation, a Tampa Bay-based health care technology firm, announced today that it is offering ownership opportunities to the participants largely responsible for its rapid growth.  The company’s rise is largely attributed to its direct involvement with the National Medication Management Initiative (NMMI).

Averlent is the main sponsor of the NMMI.  It also supplies the technology that drives the initiative’s operating platform.  The technology, combined with the initiative’s distinct business model, solves a material medication management shortcoming in the health care industry.

The groundbreaking manner in which the initiative enables physicians to offer their patients medication management assistance 24 hour per day, seven days per week, has garnered unparalleled acceptance.  The positive reception is also due, in part, to the fact that physicians and their patients do not pay a fee for the medication management service.  The initiative uses a sponsor-driven business model to generate revenue.

Averlent’s management team has opened up the firm to outside investment.  The company’s President and COO, Ron Riewold, has taken two companies public.  Riewold states: “I’ve gone to Wall Street for capital infusion on more than one occasion.  This time, we’ve decided to let the people responsible for our growth participate in our company’s success.”

Bruce Pitcher, Averlent’s CEO points out: “We’ve created our offering memorandum to let NMMI-affiliated physicians make the money that the investment bankers would otherwise make.”  Pitcher goes on to state: “It’s exciting to have an initiative that helps patients with medication management, while also providing their physicians an opportunity to partake in our company’s upside.”

Averlent Corporation can be reached by telephone at 727-448-0000.  Their email address is Contact@Averlent.com .

 

Contact Information

Bruce Pitcher

CEO

Averlent Corporation

Contact via E-mail